Greywolf Therapeutics is focused on developing novel antigen modulation treatments to guide the immune system, particularly for cancers and autoimmune disorders
Greywolf Therapeutics is focused on developing novel antigen modulation treatments to guide the immune system, particularly for cancers and autoimmune disorders. Their approach aims to modulate antigen presentation to enhance T cell recognition and targeting of diseased cells.